Skip to main content
Premium Trial:

Request an Annual Quote

German Microarray Reagent Provider Implen Opens Swiss Office

NEW YORK, Aug. 2 (GenomeWeb News) - Implen has opened an office in Switzerland, the Munich-based provider of microarray reagents said last month.


The office is located in Zumikon, near Zurich. Implen sells a wide range of microarray-related reagents for labeling, hybridization, and post-hybridization treatment.


Implen is also a distributor for Advalytix, based in Brunnthal, Germany, and for Hatfield, Penn.-based Genisphere in  Germany, Austria, and Switzerland.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.